Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection

Mariana Kikuti, Laura B. Tauro, Patrícia S.S. Moreira, Gúbio S. Campos, Igor A.D. Paploski, Scott Weaver, Mitermayer G. Reis, Uriel Kitron, Guilherme S. Ribeiro

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Serologic detection of Zika virus (ZIKV) infections is challenging because of antigenic similarities among flaviviruses. Objective: To evaluate the sensitivity and specificity of commercial ZIKV IgM and IgG enzyme-linked immunoassay (ELISA) kits. Methods: We used sera from febrile patients with RT-PCR-confirmed ZIKV infection to determine sensitivity and sera from RT-PCR-confirmed dengue cases and blood donors, both of which were collected before ZIKV epidemics in Brazil (2009-2011 and 2013, respectively) to determine specificity. Results: The ZIKV IgM-ELISA positivity among RT-PCR ZIKV confirmed cases was 0.0% (0/14) and 12.5% (1/8) for acute- and convalescent-phase sera, respectively, while its specificity was 100.0% (58/58) and 98.3% (58/59) for acute- and convalescent-phase sera of dengue patients, and 100.0% (23/23) for blood donors. The ZIKV IgG-ELISA sensitivity was 100.0% (6/6) on convalescent-phase sera from RT-PCR confirmed ZIKV patients, while its specificity was 27.3% (15/55) on convalescent-phase sera from dengue patients and 45.0% (9/20) on blood donors' sera. The ZIKV IgG-ELISA specificity among dengue confirmed cases was much greater among patients with primary dengue (92.3%; 12/13), compared to secondary dengue (7.1%; 3/42). Conclusions: In a setting of endemic dengue transmission, the ZIKV IgM-ELISA had high specificity, but poor sensitivity. In contrast, the ZIKV IgG-ELISA showed low specificity, particularly for patients previously exposed to dengue infections. This suggests that this ZIKV IgM-ELISA is not useful in confirming a diagnosis of ZIKV infection in suspected patients, whereas the IgG-ELISA is more suitable for ZIKV diagnosis among travelers, who reside in areas free of flavivirus transmission, rather than for serosurveys in dengue-endemic areas.

Original languageEnglish (US)
Article number108
JournalVirology Journal
Volume15
Issue number1
DOIs
StatePublished - Jul 13 2018

Fingerprint

Immunoenzyme Techniques
Dengue
Immunoglobulin M
Immunoglobulin G
Serum
Blood Donors
Flavivirus
Polymerase Chain Reaction
Zika Virus Infection
Zika Virus
Sensitivity and Specificity
Brazil
Fever

Keywords

  • Enzyme-linked immunosorbent assay
  • Immunoglobulin G
  • Immunoglobulin M
  • Sensitivity and specificity
  • Zika virus

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection. / Kikuti, Mariana; Tauro, Laura B.; Moreira, Patrícia S.S.; Campos, Gúbio S.; Paploski, Igor A.D.; Weaver, Scott; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.

In: Virology Journal, Vol. 15, No. 1, 108, 13.07.2018.

Research output: Contribution to journalArticle

Kikuti, M, Tauro, LB, Moreira, PSS, Campos, GS, Paploski, IAD, Weaver, S, Reis, MG, Kitron, U & Ribeiro, GS 2018, 'Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection', Virology Journal, vol. 15, no. 1, 108. https://doi.org/10.1186/s12985-018-1015-6
Kikuti, Mariana ; Tauro, Laura B. ; Moreira, Patrícia S.S. ; Campos, Gúbio S. ; Paploski, Igor A.D. ; Weaver, Scott ; Reis, Mitermayer G. ; Kitron, Uriel ; Ribeiro, Guilherme S. / Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection. In: Virology Journal. 2018 ; Vol. 15, No. 1.
@article{989189522b684515b069effb772121f6,
title = "Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection",
abstract = "Background: Serologic detection of Zika virus (ZIKV) infections is challenging because of antigenic similarities among flaviviruses. Objective: To evaluate the sensitivity and specificity of commercial ZIKV IgM and IgG enzyme-linked immunoassay (ELISA) kits. Methods: We used sera from febrile patients with RT-PCR-confirmed ZIKV infection to determine sensitivity and sera from RT-PCR-confirmed dengue cases and blood donors, both of which were collected before ZIKV epidemics in Brazil (2009-2011 and 2013, respectively) to determine specificity. Results: The ZIKV IgM-ELISA positivity among RT-PCR ZIKV confirmed cases was 0.0{\%} (0/14) and 12.5{\%} (1/8) for acute- and convalescent-phase sera, respectively, while its specificity was 100.0{\%} (58/58) and 98.3{\%} (58/59) for acute- and convalescent-phase sera of dengue patients, and 100.0{\%} (23/23) for blood donors. The ZIKV IgG-ELISA sensitivity was 100.0{\%} (6/6) on convalescent-phase sera from RT-PCR confirmed ZIKV patients, while its specificity was 27.3{\%} (15/55) on convalescent-phase sera from dengue patients and 45.0{\%} (9/20) on blood donors' sera. The ZIKV IgG-ELISA specificity among dengue confirmed cases was much greater among patients with primary dengue (92.3{\%}; 12/13), compared to secondary dengue (7.1{\%}; 3/42). Conclusions: In a setting of endemic dengue transmission, the ZIKV IgM-ELISA had high specificity, but poor sensitivity. In contrast, the ZIKV IgG-ELISA showed low specificity, particularly for patients previously exposed to dengue infections. This suggests that this ZIKV IgM-ELISA is not useful in confirming a diagnosis of ZIKV infection in suspected patients, whereas the IgG-ELISA is more suitable for ZIKV diagnosis among travelers, who reside in areas free of flavivirus transmission, rather than for serosurveys in dengue-endemic areas.",
keywords = "Enzyme-linked immunosorbent assay, Immunoglobulin G, Immunoglobulin M, Sensitivity and specificity, Zika virus",
author = "Mariana Kikuti and Tauro, {Laura B.} and Moreira, {Patr{\'i}cia S.S.} and Campos, {G{\'u}bio S.} and Paploski, {Igor A.D.} and Scott Weaver and Reis, {Mitermayer G.} and Uriel Kitron and Ribeiro, {Guilherme S.}",
year = "2018",
month = "7",
day = "13",
doi = "10.1186/s12985-018-1015-6",
language = "English (US)",
volume = "15",
journal = "Virology Journal",
issn = "1743-422X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection

AU - Kikuti, Mariana

AU - Tauro, Laura B.

AU - Moreira, Patrícia S.S.

AU - Campos, Gúbio S.

AU - Paploski, Igor A.D.

AU - Weaver, Scott

AU - Reis, Mitermayer G.

AU - Kitron, Uriel

AU - Ribeiro, Guilherme S.

PY - 2018/7/13

Y1 - 2018/7/13

N2 - Background: Serologic detection of Zika virus (ZIKV) infections is challenging because of antigenic similarities among flaviviruses. Objective: To evaluate the sensitivity and specificity of commercial ZIKV IgM and IgG enzyme-linked immunoassay (ELISA) kits. Methods: We used sera from febrile patients with RT-PCR-confirmed ZIKV infection to determine sensitivity and sera from RT-PCR-confirmed dengue cases and blood donors, both of which were collected before ZIKV epidemics in Brazil (2009-2011 and 2013, respectively) to determine specificity. Results: The ZIKV IgM-ELISA positivity among RT-PCR ZIKV confirmed cases was 0.0% (0/14) and 12.5% (1/8) for acute- and convalescent-phase sera, respectively, while its specificity was 100.0% (58/58) and 98.3% (58/59) for acute- and convalescent-phase sera of dengue patients, and 100.0% (23/23) for blood donors. The ZIKV IgG-ELISA sensitivity was 100.0% (6/6) on convalescent-phase sera from RT-PCR confirmed ZIKV patients, while its specificity was 27.3% (15/55) on convalescent-phase sera from dengue patients and 45.0% (9/20) on blood donors' sera. The ZIKV IgG-ELISA specificity among dengue confirmed cases was much greater among patients with primary dengue (92.3%; 12/13), compared to secondary dengue (7.1%; 3/42). Conclusions: In a setting of endemic dengue transmission, the ZIKV IgM-ELISA had high specificity, but poor sensitivity. In contrast, the ZIKV IgG-ELISA showed low specificity, particularly for patients previously exposed to dengue infections. This suggests that this ZIKV IgM-ELISA is not useful in confirming a diagnosis of ZIKV infection in suspected patients, whereas the IgG-ELISA is more suitable for ZIKV diagnosis among travelers, who reside in areas free of flavivirus transmission, rather than for serosurveys in dengue-endemic areas.

AB - Background: Serologic detection of Zika virus (ZIKV) infections is challenging because of antigenic similarities among flaviviruses. Objective: To evaluate the sensitivity and specificity of commercial ZIKV IgM and IgG enzyme-linked immunoassay (ELISA) kits. Methods: We used sera from febrile patients with RT-PCR-confirmed ZIKV infection to determine sensitivity and sera from RT-PCR-confirmed dengue cases and blood donors, both of which were collected before ZIKV epidemics in Brazil (2009-2011 and 2013, respectively) to determine specificity. Results: The ZIKV IgM-ELISA positivity among RT-PCR ZIKV confirmed cases was 0.0% (0/14) and 12.5% (1/8) for acute- and convalescent-phase sera, respectively, while its specificity was 100.0% (58/58) and 98.3% (58/59) for acute- and convalescent-phase sera of dengue patients, and 100.0% (23/23) for blood donors. The ZIKV IgG-ELISA sensitivity was 100.0% (6/6) on convalescent-phase sera from RT-PCR confirmed ZIKV patients, while its specificity was 27.3% (15/55) on convalescent-phase sera from dengue patients and 45.0% (9/20) on blood donors' sera. The ZIKV IgG-ELISA specificity among dengue confirmed cases was much greater among patients with primary dengue (92.3%; 12/13), compared to secondary dengue (7.1%; 3/42). Conclusions: In a setting of endemic dengue transmission, the ZIKV IgM-ELISA had high specificity, but poor sensitivity. In contrast, the ZIKV IgG-ELISA showed low specificity, particularly for patients previously exposed to dengue infections. This suggests that this ZIKV IgM-ELISA is not useful in confirming a diagnosis of ZIKV infection in suspected patients, whereas the IgG-ELISA is more suitable for ZIKV diagnosis among travelers, who reside in areas free of flavivirus transmission, rather than for serosurveys in dengue-endemic areas.

KW - Enzyme-linked immunosorbent assay

KW - Immunoglobulin G

KW - Immunoglobulin M

KW - Sensitivity and specificity

KW - Zika virus

UR - http://www.scopus.com/inward/record.url?scp=85049982621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049982621&partnerID=8YFLogxK

U2 - 10.1186/s12985-018-1015-6

DO - 10.1186/s12985-018-1015-6

M3 - Article

VL - 15

JO - Virology Journal

JF - Virology Journal

SN - 1743-422X

IS - 1

M1 - 108

ER -